• Busca persones
• Intranet

Poli (ADP-ribosa) polimerases José Yelamos

Publicacions 2024 (7)

• Mur-Gimeno E, Coll M, Yuguero-Ortiz A, Navarro M, Vernet-Tomas M, Noguera A, Sebio-García R^*. Comparison of water- vs. land-based exercise for improving functional capacity and quality of life in patients living with and beyond breast cancer (the AQUA-FiT study): a randomized controlled trial. Breast Cancer 2024: (en Premsa).
• Papaleo NF, Molina-Alvarez A, Tapia G, Onieva R, Salido M, Lome-Maldonado C, Ara-Mancebo X, Puiggros A, Espinet B, Blazquez C, Fuertes D, Sánchez-González B, Yelamos J, Calvo X, Colomo L^*. Combined immunohistochemical profile CD10/LMO2/MYC is a useful tool to screen MYC rearrangements in aggressive large B-cell lymphomas. Virchows Arch 2024: (en Premsa).
• Vernet-Tomas M^*, Vazquez I, Olivares F, Lopez D, Yelamos J, Comerma L. Human Leukocyte Antigen Class I Expression and Natural Killer Cell Infiltration and Its Correlation with Prognostic Features in Luminal Breast Cancers. Breast Cancer 2024; 16: 657-666 (Acceptat).
• Szántó M, Yelamos J^*, Bai P^*. Specific and shared biological functions of PARP2 - is PARP2 really a lil' brother of PARP1?. Expert Rev Mol Med . 2024; 26: e13.
• Papaleo NF, Molina-Alvarez A, Onieva R, Fuertes D, Sánchez-González B, Riera X, Lopez-Segura D, Lome-Maldonado C, Ara-Mancebo X, Yelamos J, Salido M, Vazquez I, Calvo X, Colomo L^*. Chromogenic LMO2 mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS. Cancers 2024; 16(13): 2378.
• Pesqué D, Ciudad A, Andrades E, Soto D, Gimeno R, Pujol RM, Giménez-Arnau AM^*. Solar Urticaria: An Ambispective Study in a Long-term Follow-up Cohort with Emphasis on Therapeutic Predictors and Outcomes. Acta Derm-Venereol 2024; 104: adv25576.
• Nicolau P, Maso P, Argudo N, JIMÉNEZ M, Martinez AI, Vazquez I, Comerma L, Vernet-Tomas M^*. P53 expression correlates with low axillary tumor burden in breast cancer. Breast Dis . 2024; 42(1): 429-435.